{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:41:01Z","timestamp":1774568461338,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,10,13]],"date-time":"2010-10-13T00:00:00Z","timestamp":1286928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s12031-010-9460-8","type":"journal-article","created":{"date-parts":[[2010,10,13]],"date-time":"2010-10-13T12:10:34Z","timestamp":1286971834000},"page":"424-427","source":"Crossref","is-referenced-by-count":22,"title":["Intranasal Phosphoramidon Increases Beta-Amyloid Levels in Wild-Type and NEP\/NEP2-Deficient Mice"],"prefix":"10.1007","volume":"43","author":[{"given":"Leah R.","family":"Hanson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Hafez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleta L.","family":"Svitak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel B.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"II","given":"William H.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Marr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,13]]},"reference":[{"key":"9460_CR1","doi-asserted-by":"publisher","first-page":"4428","DOI":"10.1128\/MCB.24.10.4428-4437.2004","volume":"24","author":"M Carpentier","year":"2004","unstructured":"Carpentier M, Guillemette C, Bailey JL, Boileau G, Jeannotte L, DesGroseillers L, Charron J (2004) Reduced fertility in male mice deficient in the zinc metallopeptidase NL1. Mol Cell Biol 24:4428\u20134437","journal-title":"Mol Cell Biol"},{"key":"9460_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ejcb.2009.02.001","volume":"88","author":"L Danielyan","year":"2009","unstructured":"Danielyan L, Schafer R, von Ameln-Mayerhofer A, Buadze M, Geisler J, Klopfer T, Burkhardt U, Proksch B, Verleysdonk S, Ayturan M, Buniatian GH, Gleiter CH, Frey WH 2nd (2009) Intranasal delivery of cells to the brain. Eur J Cell Biol 88:315\u2013324","journal-title":"Eur J Cell Biol"},{"key":"9460_CR3","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","volume":"99","author":"SV Dhuria","year":"2010","unstructured":"Dhuria SV, Hanson LR, Frey WH 2nd (2010) Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci 99:1654\u20131673","journal-title":"J Pharm Sci"},{"key":"9460_CR4","doi-asserted-by":"publisher","first-page":"13909","DOI":"10.1073\/pnas.0404458101","volume":"101","author":"I Dolev","year":"2004","unstructured":"Dolev I, Michaelson DM (2004) A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade. Proc Natl Acad Sci USA 101:13909\u201313914","journal-title":"Proc Natl Acad Sci USA"},{"key":"9460_CR5","doi-asserted-by":"crossref","unstructured":"Hafez D, Huang JY, Huynh AM, Valtierra S, Rockenstein E, Bruno AM, Lu B, DesGroseillers L, Masliah E, Marr RA (2010) Neprilysin-2 is an important beta- amloid degrading enzyme. Am J Pathol (in press)","DOI":"10.1016\/j.ajpath.2010.11.012"},{"issue":"Suppl 3","key":"9460_CR6","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1186\/1471-2202-9-S3-S5","volume":"9","author":"LR Hanson","year":"2008","unstructured":"Hanson LR, Frey WH 2nd (2008) Intranasal delivery bypasses the blood\u2013brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci 9(Suppl 3):S5","journal-title":"BMC Neurosci"},{"key":"9460_CR7","first-page":"66","volume":"4","author":"LR Hanson","year":"2004","unstructured":"Hanson LR, Martinez PM, Taheri S, Kamsheh L, Mignot E, Frey WHI (2004) Intranasal administration of hypocretin 1 (Orexin A) bypasses the blood\u2013brain barrier & targets the brain: a new strategy for the treatment of narcolepsy. Drug Deliv Technol 4:66\u201371","journal-title":"Drug Deliv Technol"},{"key":"9460_CR8","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1124\/jpet.108.149807","volume":"330","author":"LR Hanson","year":"2009","unstructured":"Hanson LR, Roeytenberg A, Martinez PM, Coppes VG, Sweet DC, Rao RJ, Marti DL, Hoekman JD, Matthews RB, Frey WH 2nd, Panter SS (2009) Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke. J Pharmacol Exp Ther 330:679\u2013686","journal-title":"J Pharmacol Exp Ther"},{"key":"9460_CR9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.neuroscience.2008.05.006","volume":"155","author":"JY Huang","year":"2008","unstructured":"Huang JY, Bruno AM, Patel CA, Huynh AM, Philibert KD, Glucksman MJ, Marr RA (2008) Human membrane metallo-endopeptidase-like protein degrades both beta-amyloid 42 and beta-amyloid 40. Neuroscience 155:258\u2013262","journal-title":"Neuroscience"},{"key":"9460_CR10","doi-asserted-by":"publisher","first-page":"32469","DOI":"10.1074\/jbc.274.45.32469","volume":"274","author":"K Ikeda","year":"1999","unstructured":"Ikeda K, Emoto N, Raharjo SB, Nurhantari Y, Saiki K, Yokoyama M, Matsuo M (1999) Molecular identification and characterization of novel membrane-bound metalloprotease, the soluble secreted form of which hydrolyzes a variety of vasoactive peptides. J Biol Chem 274:32469\u201332477","journal-title":"J Biol Chem"},{"key":"9460_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/77399","volume":"6","author":"N Iwata","year":"2000","unstructured":"Iwata N, Tsubuki S, Takaki Y, Watanabe K, Sekiguchi M, Hosoki E, Kawashima-Morishima M, Lee HJ, Hama E, Sekine-Aizawa Y, Saido TC (2000) Identification of the major Abeta1\u201342-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med 6:143\u2013150","journal-title":"Nat Med"},{"key":"9460_CR12","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1126\/science.1059946","volume":"292","author":"N Iwata","year":"2001","unstructured":"Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard NP, Gerard C, Hama E, Lee HJ, Saido TC (2001) Metabolic regulation of brain Abeta by neprilysin. Science 292:1550\u20131552","journal-title":"Science"},{"key":"9460_CR13","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1084\/jem.181.6.2271","volume":"181","author":"B Lu","year":"1995","unstructured":"Lu B, Gerard NP, Kolakowski LF Jr, Bozza M, Zurakowski D, Finco O, Carroll MC, Gerard C (1995) Neutral endopeptidase modulation of septic shock. J Exp Med 181:2271\u20132275","journal-title":"J Exp Med"},{"key":"9460_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2174\/156720510791050849","volume":"7","author":"RA Marr","year":"2010","unstructured":"Marr RA, Spencer BJ (2010) NEP-like endopeptidases and Alzheimer\u2019s disease. Curr Alzheimer Res 7:223\u2013229","journal-title":"Curr Alzheimer Res"},{"key":"9460_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.bbr.2005.10.014","volume":"168","author":"A Mouri","year":"2006","unstructured":"Mouri A, Zou LB, Iwata N, Saido TC, Wang D, Wang MW, Noda Y, Nabeshima T (2006) Inhibition of neprilysin by thiorphan (i.c.v.) causes an accumulation of amyloid beta and impairment of learning and memory. Behav Brain Res 168:83\u201391","journal-title":"Behav Brain Res"},{"issue":"Suppl 1","key":"9460_CR16","first-page":"1","volume":"4","author":"Y Nisemblat","year":"2007","unstructured":"Nisemblat Y, Belinson H, Dolev I, Michaelson DM (2007) Alzheimer\u2019s and Parkinson\u2019s diseases: progress and new perspectives. Abstracts of the 8th international conference AD\/PD, Salzburg, Austria, March 14\u201318, 2007. Abstracts. Neurodegener Dis 4(Suppl 1):1\u2013350","journal-title":"Neurodegener Dis"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-010-9460-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-010-9460-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-010-9460-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-010-9460-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T22:08:50Z","timestamp":1581977330000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-010-9460-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,13]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["9460"],"URL":"https:\/\/doi.org\/10.1007\/s12031-010-9460-8","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,13]]}}}